Global Non-Invasive Liquid Biopsy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Non-invasive liquid biopsy is to analyze and diagnose diseases such as cancer through blood or urine and other body fluids. At present, the main application area of liquid biopsy is the blood detection of tumors, that is, the use of blood to indicate tumor development and drug resistance and other information to guide individualized and precise treatment. Compared with existing tumor detection methods, liquid biopsy is non-invasive, can be detected frequently and repeatedly, and has rapid response capabilities. It has significant advantages and has great potential for application development.
According to our (Global Info Research) latest study, the global Non-Invasive Liquid Biopsy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Invasive Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Invasive Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Liquid Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Liquid Biopsy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG and MDxHealth, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Invasive Liquid Biopsy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-Invasive Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Liquid Biopsy, with revenue, gross margin and global market share of Non-Invasive Liquid Biopsy from 2018 to 2023.
Chapter 3, the Non-Invasive Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Invasive Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Liquid Biopsy.
Chapter 13, to describe Non-Invasive Liquid Biopsy research findings and conclusion.
According to our (Global Info Research) latest study, the global Non-Invasive Liquid Biopsy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Invasive Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Invasive Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Invasive Liquid Biopsy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Liquid Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Liquid Biopsy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, Endress+Hauser, Exact Sciences Corporation, Lonza Group AG and MDxHealth, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Invasive Liquid Biopsy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Stool Test
- Urine Test
- Saliva Test
- Others
- Hospital
- Laboratory
- Others
- Bio-Techne
- Endress+Hauser
- Exact Sciences Corporation
- Lonza Group AG
- MDxHealth
- Merck KGaA
- MutantDx
- Norgen Biotek Corp
- Nucleix
- Oasis Diagnostics Corporation
- OraSure Technologies
- PerkinElmer
- Predicine
- Qiagen
- Thermo Fisher Scientific
- Zymo Research Corporation
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-Invasive Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Liquid Biopsy, with revenue, gross margin and global market share of Non-Invasive Liquid Biopsy from 2018 to 2023.
Chapter 3, the Non-Invasive Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Invasive Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Liquid Biopsy.
Chapter 13, to describe Non-Invasive Liquid Biopsy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Invasive Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Liquid Biopsy by Type
1.3.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Type in 2022
1.3.3 Stool Test
1.3.4 Urine Test
1.3.5 Saliva Test
1.3.6 Others
1.4 Global Non-Invasive Liquid Biopsy Market by Application
1.4.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Laboratory
1.4.4 Others
1.5 Global Non-Invasive Liquid Biopsy Market Size & Forecast
1.6 Global Non-Invasive Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Non-Invasive Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Invasive Liquid Biopsy Market Size by Region, (2018-2029)
1.6.3 North America Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.6 South America Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Bio-Techne
2.1.1 Bio-Techne Details
2.1.2 Bio-Techne Major Business
2.1.3 Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
2.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio-Techne Recent Developments and Future Plans
2.2 Endress+Hauser
2.2.1 Endress+Hauser Details
2.2.2 Endress+Hauser Major Business
2.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
2.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Endress+Hauser Recent Developments and Future Plans
2.3 Exact Sciences Corporation
2.3.1 Exact Sciences Corporation Details
2.3.2 Exact Sciences Corporation Major Business
2.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Exact Sciences Corporation Recent Developments and Future Plans
2.4 Lonza Group AG
2.4.1 Lonza Group AG Details
2.4.2 Lonza Group AG Major Business
2.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
2.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lonza Group AG Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business
2.6.3 Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
2.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck KGaA Recent Developments and Future Plans
2.7 MutantDx
2.7.1 MutantDx Details
2.7.2 MutantDx Major Business
2.7.3 MutantDx Non-Invasive Liquid Biopsy Product and Solutions
2.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MutantDx Recent Developments and Future Plans
2.8 Norgen Biotek Corp
2.8.1 Norgen Biotek Corp Details
2.8.2 Norgen Biotek Corp Major Business
2.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
2.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Norgen Biotek Corp Recent Developments and Future Plans
2.9 Nucleix
2.9.1 Nucleix Details
2.9.2 Nucleix Major Business
2.9.3 Nucleix Non-Invasive Liquid Biopsy Product and Solutions
2.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nucleix Recent Developments and Future Plans
2.10 Oasis Diagnostics Corporation
2.10.1 Oasis Diagnostics Corporation Details
2.10.2 Oasis Diagnostics Corporation Major Business
2.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Oasis Diagnostics Corporation Recent Developments and Future Plans
2.11 OraSure Technologies
2.11.1 OraSure Technologies Details
2.11.2 OraSure Technologies Major Business
2.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
2.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 OraSure Technologies Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
2.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Predicine
2.13.1 Predicine Details
2.13.2 Predicine Major Business
2.13.3 Predicine Non-Invasive Liquid Biopsy Product and Solutions
2.13.4 Predicine Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Predicine Recent Developments and Future Plans
2.14 Qiagen
2.14.1 Qiagen Details
2.14.2 Qiagen Major Business
2.14.3 Qiagen Non-Invasive Liquid Biopsy Product and Solutions
2.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Qiagen Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
2.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 Zymo Research Corporation
2.16.1 Zymo Research Corporation Details
2.16.2 Zymo Research Corporation Major Business
2.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Zymo Research Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Invasive Liquid Biopsy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Invasive Liquid Biopsy by Company Revenue
3.2.2 Top 3 Non-Invasive Liquid Biopsy Players Market Share in 2022
3.2.3 Top 6 Non-Invasive Liquid Biopsy Players Market Share in 2022
3.3 Non-Invasive Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Non-Invasive Liquid Biopsy Market: Region Footprint
3.3.2 Non-Invasive Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Non-Invasive Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Invasive Liquid Biopsy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Invasive Liquid Biopsy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Invasive Liquid Biopsy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
6.2 North America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
6.3 North America Non-Invasive Liquid Biopsy Market Size by Country
6.3.1 North America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
6.3.2 United States Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
7.2 Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
7.3 Europe Non-Invasive Liquid Biopsy Market Size by Country
7.3.1 Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.3 France Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2029)
8.3.2 China Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.5 India Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
9.2 South America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
9.3 South America Non-Invasive Liquid Biopsy Market Size by Country
9.3.1 South America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Invasive Liquid Biopsy Market Drivers
11.2 Non-Invasive Liquid Biopsy Market Restraints
11.3 Non-Invasive Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Invasive Liquid Biopsy Industry Chain
12.2 Non-Invasive Liquid Biopsy Upstream Analysis
12.3 Non-Invasive Liquid Biopsy Midstream Analysis
12.4 Non-Invasive Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-Invasive Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Liquid Biopsy by Type
1.3.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Type in 2022
1.3.3 Stool Test
1.3.4 Urine Test
1.3.5 Saliva Test
1.3.6 Others
1.4 Global Non-Invasive Liquid Biopsy Market by Application
1.4.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Laboratory
1.4.4 Others
1.5 Global Non-Invasive Liquid Biopsy Market Size & Forecast
1.6 Global Non-Invasive Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Non-Invasive Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Invasive Liquid Biopsy Market Size by Region, (2018-2029)
1.6.3 North America Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.6 South America Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Invasive Liquid Biopsy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Bio-Techne
2.1.1 Bio-Techne Details
2.1.2 Bio-Techne Major Business
2.1.3 Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
2.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio-Techne Recent Developments and Future Plans
2.2 Endress+Hauser
2.2.1 Endress+Hauser Details
2.2.2 Endress+Hauser Major Business
2.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
2.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Endress+Hauser Recent Developments and Future Plans
2.3 Exact Sciences Corporation
2.3.1 Exact Sciences Corporation Details
2.3.2 Exact Sciences Corporation Major Business
2.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Exact Sciences Corporation Recent Developments and Future Plans
2.4 Lonza Group AG
2.4.1 Lonza Group AG Details
2.4.2 Lonza Group AG Major Business
2.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
2.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lonza Group AG Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business
2.6.3 Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
2.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck KGaA Recent Developments and Future Plans
2.7 MutantDx
2.7.1 MutantDx Details
2.7.2 MutantDx Major Business
2.7.3 MutantDx Non-Invasive Liquid Biopsy Product and Solutions
2.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MutantDx Recent Developments and Future Plans
2.8 Norgen Biotek Corp
2.8.1 Norgen Biotek Corp Details
2.8.2 Norgen Biotek Corp Major Business
2.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
2.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Norgen Biotek Corp Recent Developments and Future Plans
2.9 Nucleix
2.9.1 Nucleix Details
2.9.2 Nucleix Major Business
2.9.3 Nucleix Non-Invasive Liquid Biopsy Product and Solutions
2.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nucleix Recent Developments and Future Plans
2.10 Oasis Diagnostics Corporation
2.10.1 Oasis Diagnostics Corporation Details
2.10.2 Oasis Diagnostics Corporation Major Business
2.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Oasis Diagnostics Corporation Recent Developments and Future Plans
2.11 OraSure Technologies
2.11.1 OraSure Technologies Details
2.11.2 OraSure Technologies Major Business
2.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
2.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 OraSure Technologies Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
2.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Predicine
2.13.1 Predicine Details
2.13.2 Predicine Major Business
2.13.3 Predicine Non-Invasive Liquid Biopsy Product and Solutions
2.13.4 Predicine Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Predicine Recent Developments and Future Plans
2.14 Qiagen
2.14.1 Qiagen Details
2.14.2 Qiagen Major Business
2.14.3 Qiagen Non-Invasive Liquid Biopsy Product and Solutions
2.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Qiagen Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
2.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 Zymo Research Corporation
2.16.1 Zymo Research Corporation Details
2.16.2 Zymo Research Corporation Major Business
2.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Zymo Research Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Invasive Liquid Biopsy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Invasive Liquid Biopsy by Company Revenue
3.2.2 Top 3 Non-Invasive Liquid Biopsy Players Market Share in 2022
3.2.3 Top 6 Non-Invasive Liquid Biopsy Players Market Share in 2022
3.3 Non-Invasive Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Non-Invasive Liquid Biopsy Market: Region Footprint
3.3.2 Non-Invasive Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Non-Invasive Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Invasive Liquid Biopsy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Invasive Liquid Biopsy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Invasive Liquid Biopsy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
6.2 North America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
6.3 North America Non-Invasive Liquid Biopsy Market Size by Country
6.3.1 North America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
6.3.2 United States Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
7.2 Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
7.3 Europe Non-Invasive Liquid Biopsy Market Size by Country
7.3.1 Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.3 France Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2029)
8.3.2 China Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.5 India Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
9.2 South America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
9.3 South America Non-Invasive Liquid Biopsy Market Size by Country
9.3.1 South America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Invasive Liquid Biopsy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-Invasive Liquid Biopsy Market Drivers
11.2 Non-Invasive Liquid Biopsy Market Restraints
11.3 Non-Invasive Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Invasive Liquid Biopsy Industry Chain
12.2 Non-Invasive Liquid Biopsy Upstream Analysis
12.3 Non-Invasive Liquid Biopsy Midstream Analysis
12.4 Non-Invasive Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Invasive Liquid Biopsy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Invasive Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Bio-Techne Company Information, Head Office, and Major Competitors
Table 6. Bio-Techne Major Business
Table 7. Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
Table 8. Bio-Techne Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Bio-Techne Recent Developments and Future Plans
Table 10. Endress+Hauser Company Information, Head Office, and Major Competitors
Table 11. Endress+Hauser Major Business
Table 12. Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
Table 13. Endress+Hauser Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Endress+Hauser Recent Developments and Future Plans
Table 15. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 16. Exact Sciences Corporation Major Business
Table 17. Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 18. Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Exact Sciences Corporation Recent Developments and Future Plans
Table 20. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 21. Lonza Group AG Major Business
Table 22. Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
Table 23. Lonza Group AG Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Lonza Group AG Recent Developments and Future Plans
Table 25. MDxHealth Company Information, Head Office, and Major Competitors
Table 26. MDxHealth Major Business
Table 27. MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
Table 28. MDxHealth Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. MDxHealth Recent Developments and Future Plans
Table 30. Merck KGaA Company Information, Head Office, and Major Competitors
Table 31. Merck KGaA Major Business
Table 32. Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
Table 33. Merck KGaA Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck KGaA Recent Developments and Future Plans
Table 35. MutantDx Company Information, Head Office, and Major Competitors
Table 36. MutantDx Major Business
Table 37. MutantDx Non-Invasive Liquid Biopsy Product and Solutions
Table 38. MutantDx Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. MutantDx Recent Developments and Future Plans
Table 40. Norgen Biotek Corp Company Information, Head Office, and Major Competitors
Table 41. Norgen Biotek Corp Major Business
Table 42. Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
Table 43. Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Norgen Biotek Corp Recent Developments and Future Plans
Table 45. Nucleix Company Information, Head Office, and Major Competitors
Table 46. Nucleix Major Business
Table 47. Nucleix Non-Invasive Liquid Biopsy Product and Solutions
Table 48. Nucleix Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nucleix Recent Developments and Future Plans
Table 50. Oasis Diagnostics Corporation Company Information, Head Office, and Major Competitors
Table 51. Oasis Diagnostics Corporation Major Business
Table 52. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 53. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Oasis Diagnostics Corporation Recent Developments and Future Plans
Table 55. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 56. OraSure Technologies Major Business
Table 57. OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
Table 58. OraSure Technologies Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. OraSure Technologies Recent Developments and Future Plans
Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
Table 61. PerkinElmer Major Business
Table 62. PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
Table 63. PerkinElmer Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. PerkinElmer Recent Developments and Future Plans
Table 65. Predicine Company Information, Head Office, and Major Competitors
Table 66. Predicine Major Business
Table 67. Predicine Non-Invasive Liquid Biopsy Product and Solutions
Table 68. Predicine Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Predicine Recent Developments and Future Plans
Table 70. Qiagen Company Information, Head Office, and Major Competitors
Table 71. Qiagen Major Business
Table 72. Qiagen Non-Invasive Liquid Biopsy Product and Solutions
Table 73. Qiagen Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Qiagen Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
Table 78. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Zymo Research Corporation Company Information, Head Office, and Major Competitors
Table 81. Zymo Research Corporation Major Business
Table 82. Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 83. Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Zymo Research Corporation Recent Developments and Future Plans
Table 85. Global Non-Invasive Liquid Biopsy Revenue (USD Million) by Players (2018-2023)
Table 86. Global Non-Invasive Liquid Biopsy Revenue Share by Players (2018-2023)
Table 87. Breakdown of Non-Invasive Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Non-Invasive Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Non-Invasive Liquid Biopsy Players
Table 90. Non-Invasive Liquid Biopsy Market: Company Product Type Footprint
Table 91. Non-Invasive Liquid Biopsy Market: Company Product Application Footprint
Table 92. Non-Invasive Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 93. Non-Invasive Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Non-Invasive Liquid Biopsy Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Non-Invasive Liquid Biopsy Consumption Value Share by Type (2018-2023)
Table 96. Global Non-Invasive Liquid Biopsy Consumption Value Forecast by Type (2024-2029)
Table 97. Global Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023)
Table 98. Global Non-Invasive Liquid Biopsy Consumption Value Forecast by Application (2024-2029)
Table 99. North America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Non-Invasive Liquid Biopsy Raw Material
Table 130. Key Suppliers of Non-Invasive Liquid Biopsy Raw Materials
Table 1. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Invasive Liquid Biopsy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Invasive Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Bio-Techne Company Information, Head Office, and Major Competitors
Table 6. Bio-Techne Major Business
Table 7. Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
Table 8. Bio-Techne Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Bio-Techne Recent Developments and Future Plans
Table 10. Endress+Hauser Company Information, Head Office, and Major Competitors
Table 11. Endress+Hauser Major Business
Table 12. Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
Table 13. Endress+Hauser Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Endress+Hauser Recent Developments and Future Plans
Table 15. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 16. Exact Sciences Corporation Major Business
Table 17. Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 18. Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Exact Sciences Corporation Recent Developments and Future Plans
Table 20. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 21. Lonza Group AG Major Business
Table 22. Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
Table 23. Lonza Group AG Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Lonza Group AG Recent Developments and Future Plans
Table 25. MDxHealth Company Information, Head Office, and Major Competitors
Table 26. MDxHealth Major Business
Table 27. MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
Table 28. MDxHealth Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. MDxHealth Recent Developments and Future Plans
Table 30. Merck KGaA Company Information, Head Office, and Major Competitors
Table 31. Merck KGaA Major Business
Table 32. Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
Table 33. Merck KGaA Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck KGaA Recent Developments and Future Plans
Table 35. MutantDx Company Information, Head Office, and Major Competitors
Table 36. MutantDx Major Business
Table 37. MutantDx Non-Invasive Liquid Biopsy Product and Solutions
Table 38. MutantDx Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. MutantDx Recent Developments and Future Plans
Table 40. Norgen Biotek Corp Company Information, Head Office, and Major Competitors
Table 41. Norgen Biotek Corp Major Business
Table 42. Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
Table 43. Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Norgen Biotek Corp Recent Developments and Future Plans
Table 45. Nucleix Company Information, Head Office, and Major Competitors
Table 46. Nucleix Major Business
Table 47. Nucleix Non-Invasive Liquid Biopsy Product and Solutions
Table 48. Nucleix Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nucleix Recent Developments and Future Plans
Table 50. Oasis Diagnostics Corporation Company Information, Head Office, and Major Competitors
Table 51. Oasis Diagnostics Corporation Major Business
Table 52. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 53. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Oasis Diagnostics Corporation Recent Developments and Future Plans
Table 55. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 56. OraSure Technologies Major Business
Table 57. OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
Table 58. OraSure Technologies Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. OraSure Technologies Recent Developments and Future Plans
Table 60. PerkinElmer Company Information, Head Office, and Major Competitors
Table 61. PerkinElmer Major Business
Table 62. PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
Table 63. PerkinElmer Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. PerkinElmer Recent Developments and Future Plans
Table 65. Predicine Company Information, Head Office, and Major Competitors
Table 66. Predicine Major Business
Table 67. Predicine Non-Invasive Liquid Biopsy Product and Solutions
Table 68. Predicine Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Predicine Recent Developments and Future Plans
Table 70. Qiagen Company Information, Head Office, and Major Competitors
Table 71. Qiagen Major Business
Table 72. Qiagen Non-Invasive Liquid Biopsy Product and Solutions
Table 73. Qiagen Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Qiagen Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
Table 78. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Zymo Research Corporation Company Information, Head Office, and Major Competitors
Table 81. Zymo Research Corporation Major Business
Table 82. Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 83. Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Zymo Research Corporation Recent Developments and Future Plans
Table 85. Global Non-Invasive Liquid Biopsy Revenue (USD Million) by Players (2018-2023)
Table 86. Global Non-Invasive Liquid Biopsy Revenue Share by Players (2018-2023)
Table 87. Breakdown of Non-Invasive Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Non-Invasive Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Non-Invasive Liquid Biopsy Players
Table 90. Non-Invasive Liquid Biopsy Market: Company Product Type Footprint
Table 91. Non-Invasive Liquid Biopsy Market: Company Product Application Footprint
Table 92. Non-Invasive Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 93. Non-Invasive Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Non-Invasive Liquid Biopsy Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Non-Invasive Liquid Biopsy Consumption Value Share by Type (2018-2023)
Table 96. Global Non-Invasive Liquid Biopsy Consumption Value Forecast by Type (2024-2029)
Table 97. Global Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023)
Table 98. Global Non-Invasive Liquid Biopsy Consumption Value Forecast by Application (2024-2029)
Table 99. North America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Non-Invasive Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Non-Invasive Liquid Biopsy Raw Material
Table 130. Key Suppliers of Non-Invasive Liquid Biopsy Raw Materials
LIST OF FIGURES
Figure 1. Non-Invasive Liquid Biopsy Picture
Figure 2. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Type in 2022
Figure 4. Stool Test
Figure 5. Urine Test
Figure 6. Saliva Test
Figure 7. Others
Figure 8. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Non-Invasive Liquid Biopsy Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Laboratory Picture
Figure 12. Others Picture
Figure 13. Global Non-Invasive Liquid Biopsy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Non-Invasive Liquid Biopsy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Non-Invasive Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Region in 2022
Figure 18. North America Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Non-Invasive Liquid Biopsy Revenue Share by Players in 2022
Figure 24. Non-Invasive Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Non-Invasive Liquid Biopsy Market Share in 2022
Figure 26. Global Top 6 Players Non-Invasive Liquid Biopsy Market Share in 2022
Figure 27. Global Non-Invasive Liquid Biopsy Consumption Value Share by Type (2018-2023)
Figure 28. Global Non-Invasive Liquid Biopsy Market Share Forecast by Type (2024-2029)
Figure 29. Global Non-Invasive Liquid Biopsy Consumption Value Share by Application (2018-2023)
Figure 30. Global Non-Invasive Liquid Biopsy Market Share Forecast by Application (2024-2029)
Figure 31. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 41. France Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 48. China Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 51. India Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 65. Non-Invasive Liquid Biopsy Market Drivers
Figure 66. Non-Invasive Liquid Biopsy Market Restraints
Figure 67. Non-Invasive Liquid Biopsy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Non-Invasive Liquid Biopsy in 2022
Figure 70. Manufacturing Process Analysis of Non-Invasive Liquid Biopsy
Figure 71. Non-Invasive Liquid Biopsy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Non-Invasive Liquid Biopsy Picture
Figure 2. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Type in 2022
Figure 4. Stool Test
Figure 5. Urine Test
Figure 6. Saliva Test
Figure 7. Others
Figure 8. Global Non-Invasive Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Non-Invasive Liquid Biopsy Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Laboratory Picture
Figure 12. Others Picture
Figure 13. Global Non-Invasive Liquid Biopsy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Non-Invasive Liquid Biopsy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Non-Invasive Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Non-Invasive Liquid Biopsy Consumption Value Market Share by Region in 2022
Figure 18. North America Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Non-Invasive Liquid Biopsy Revenue Share by Players in 2022
Figure 24. Non-Invasive Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Non-Invasive Liquid Biopsy Market Share in 2022
Figure 26. Global Top 6 Players Non-Invasive Liquid Biopsy Market Share in 2022
Figure 27. Global Non-Invasive Liquid Biopsy Consumption Value Share by Type (2018-2023)
Figure 28. Global Non-Invasive Liquid Biopsy Market Share Forecast by Type (2024-2029)
Figure 29. Global Non-Invasive Liquid Biopsy Consumption Value Share by Application (2018-2023)
Figure 30. Global Non-Invasive Liquid Biopsy Market Share Forecast by Application (2024-2029)
Figure 31. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 41. France Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Non-Invasive Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 48. China Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 51. India Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Non-Invasive Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Non-Invasive Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 65. Non-Invasive Liquid Biopsy Market Drivers
Figure 66. Non-Invasive Liquid Biopsy Market Restraints
Figure 67. Non-Invasive Liquid Biopsy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Non-Invasive Liquid Biopsy in 2022
Figure 70. Manufacturing Process Analysis of Non-Invasive Liquid Biopsy
Figure 71. Non-Invasive Liquid Biopsy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
